Related Experiment Videos
Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE)-induced hepatic insulin
T Yoshida1, S Yamagishi, K Nakamura
1Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Abstract:
Advanced glycation end products (AGEs) could be implicated in insulin resistance. However, the molecular mechanisms underlying this are not fully understood. Since pigment epithelium-derived factor (PEDF) blocks the AGE-signaling pathways, we examined here whether and how PEDF improves insulin resistance in AGE-exposed hepatoma cells, Hep3B cells. Proteins were extracted from Hep3B cells, immunoprecipitated with or without insulin receptor substrate-1 (IRS-1) antibodies, and subjected to Western blot analysis. Glycogen synthesis was measured using [ (14)C]-d-glucose. AGE induced Rac-1 activation and increased phosphorylation of IRS-1 at serine-307 residues, JNK, c-JUN, and IkappaB kinase in association with decreased IkappaB levels in Hep3B cells. PEDF or overexpression of dominant negative Rac-1 blocked these effects of AGE on Hep3B cells. Further, AGEs decreased tyrosine phosphorylation of IRS-1, and subsequently reduced the association of p85 subunit of phosphatidylinositol 3-kinase with IRS-1 and glycogen synthesis in insulin-exposed Hep3B cells, all of which were inhibited by PEDF. Our present study suggests that PEDF could improve the AGE-elicited insulin resistance in Hep3B cells by inhibiting JNK- and IkappaB kinase-dependent serine phosphorylation of IRS-1 via suppression of Rac-1 activation. PEDF may play a protective role against hepatic insulin resistance in diabetes.
Insights
Pigment epithelium-derived factor (PEDF) combats insulin resistance caused by advanced glycation end products (AGEs). PEDF improves AGE-induced insulin resistance in liver cells by blocking key signaling pathways, suggesting a protective role in diabetes.
Area of Science:
- Cell Biology
- Endocrinology
- Biochemistry
Background:
- Advanced glycation end products (AGEs) are linked to insulin resistance, but underlying mechanisms remain unclear.
- Pigment epithelium-derived factor (PEDF) is known to inhibit AGE-signaling pathways.
- Understanding PEDF's role in AGE-induced insulin resistance is crucial for potential therapeutic strategies.
Purpose of the Study:
- To investigate whether PEDF improves insulin resistance in AGE-exposed hepatoma cells (Hep3B).
- To elucidate the molecular mechanisms by which PEDF exerts its protective effects against AGEs.
- To determine PEDF's potential role in combating hepatic insulin resistance.
Main Methods:
- Proteins from AGE-exposed Hep3B cells were analyzed using Western blot and immunoprecipitation.
- Insulin receptor substrate-1 (IRS-1) phosphorylation and interactions were assessed.
- Glycogen synthesis was measured using radiolabeled glucose ([ (14)C]-d-glucose).
- The role of Rac-1 activation and downstream signaling pathways (JNK, IKK) was examined.
Main Results:
- AGEs activated Rac-1, increased serine phosphorylation of IRS-1, and activated JNK and IkappaB kinase (IKK) pathways.
- PEDF inhibited AGE-induced Rac-1 activation and downstream signaling.
- AGEs reduced tyrosine phosphorylation of IRS-1, impairing PI3K association and glycogen synthesis.
- PEDF reversed these AGE-induced impairments in insulin signaling and glucose metabolism.
Conclusions:
- PEDF improves AGE-elicited insulin resistance in Hep3B cells by suppressing Rac-1 activation.
- PEDF inhibits JNK- and IKK-dependent serine phosphorylation of IRS-1.
- PEDF may offer a protective effect against hepatic insulin resistance in diabetes.
Related Concept Videos
Cell Specific Gene Expression
Diabetic Retinopathy